Result of FASTA (omim) for
pFN21AE4481
FASTA searches a protein or DNA sequence data bank 36.3.4 Apr, 2011
Please cite:
W.R. Pearson & D.J. Lipman PNAS (1988) 85:2444-2448
Query: pF1KE4481, 498 aa
1>>>pF1KE4481 498 - 498 aa - 498 aa
Library: /omim/omim.rfq.tfa
60827320 residues in 85289 sequences
Statistics: Expectation_n fit: rho(ln(x))= 7.2318+/-0.000411; mu= 9.0235+/- 0.026
mean_var=116.6518+/-23.453, 0's: 0 Z-trim(114.5): 22 B-trim: 338 in 1/57
Lambda= 0.118749
statistics sampled from 24429 (24451) to 24429 sequences
Algorithm: FASTA (3.7 Nov 2010) [optimized]
Parameters: BL50 matrix (15:-5), open/ext: -10/-2
ktup: 2, E-join: 1 (0.656), E-opt: 0.2 (0.287), width: 16
Scan time: 6.400
The best scores are: opt bits E(85289)
NP_004799 (OMIM: 603801) glycylpeptide N-tetradeca ( 498) 3343 584.0 3.3e-166
XP_005252699 (OMIM: 603801) PREDICTED: glycylpepti ( 495) 3308 578.0 2.1e-164
XP_016872436 (OMIM: 603801) PREDICTED: glycylpepti ( 502) 3308 578.0 2.1e-164
NP_001295224 (OMIM: 603801) glycylpeptide N-tetrad ( 485) 2814 493.4 6.1e-139
XP_016872438 (OMIM: 603801) PREDICTED: glycylpepti ( 482) 2779 487.4 3.9e-137
XP_016872437 (OMIM: 603801) PREDICTED: glycylpepti ( 489) 2779 487.4 3.9e-137
XP_016872442 (OMIM: 603801) PREDICTED: glycylpepti ( 411) 2772 486.2 7.8e-137
XP_016872441 (OMIM: 603801) PREDICTED: glycylpepti ( 415) 2737 480.2 5e-135
NP_066565 (OMIM: 160993) glycylpeptide N-tetradeca ( 496) 2450 431.0 3.7e-120
XP_011523160 (OMIM: 160993) PREDICTED: glycylpepti ( 515) 2125 375.4 2.2e-103
XP_006717602 (OMIM: 603801) PREDICTED: glycylpepti ( 441) 1646 293.3 9.7e-79
XP_016872439 (OMIM: 603801) PREDICTED: glycylpepti ( 445) 1646 293.3 9.8e-79
XP_016872440 (OMIM: 603801) PREDICTED: glycylpepti ( 428) 1349 242.4 2e-63
>>NP_004799 (OMIM: 603801) glycylpeptide N-tetradecanoyl (498 aa)
initn: 3343 init1: 3343 opt: 3343 Z-score: 3105.0 bits: 584.0 E(85289): 3.3e-166
Smith-Waterman score: 3343; 99.8% identity (100.0% similar) in 498 aa overlap (1-498:1-498)
10 20 30 40 50 60
pF1KE4 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 RSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK
:::::.::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 RSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK
310 320 330 340 350 360
370 380 390 400 410 420
pF1KE4 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA
370 380 390 400 410 420
430 440 450 460 470 480
pF1KE4 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_004 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL
430 440 450 460 470 480
490
pF1KE4 YNWRCPGTDSEKVGLVLQ
::::::::::::::::::
NP_004 YNWRCPGTDSEKVGLVLQ
490
>>XP_005252699 (OMIM: 603801) PREDICTED: glycylpeptide N (495 aa)
initn: 3308 init1: 3308 opt: 3308 Z-score: 3072.7 bits: 578.0 E(85289): 2.1e-164
Smith-Waterman score: 3308; 99.8% identity (100.0% similar) in 492 aa overlap (1-492:1-492)
10 20 30 40 50 60
pF1KE4 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 RSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK
:::::.::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 RSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK
310 320 330 340 350 360
370 380 390 400 410 420
pF1KE4 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA
370 380 390 400 410 420
430 440 450 460 470 480
pF1KE4 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_005 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL
430 440 450 460 470 480
490
pF1KE4 YNWRCPGTDSEKVGLVLQ
::::::::::::
XP_005 YNWRCPGTDSEKKVC
490
>>XP_016872436 (OMIM: 603801) PREDICTED: glycylpeptide N (502 aa)
initn: 3308 init1: 3308 opt: 3308 Z-score: 3072.6 bits: 578.0 E(85289): 2.1e-164
Smith-Waterman score: 3308; 99.8% identity (100.0% similar) in 492 aa overlap (1-492:1-492)
10 20 30 40 50 60
pF1KE4 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 MAEDSESAASQQSLELDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPN
10 20 30 40 50 60
70 80 90 100 110 120
pF1KE4 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 SGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQ
70 80 90 100 110 120
130 140 150 160 170 180
pF1KE4 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 FWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNE
130 140 150 160 170 180
190 200 210 220 230 240
pF1KE4 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 NYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDS
190 200 210 220 230 240
250 260 270 280 290 300
pF1KE4 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 VKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWH
250 260 270 280 290 300
310 320 330 340 350 360
pF1KE4 RSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK
:::::.::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 RSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLK
310 320 330 340 350 360
370 380 390 400 410 420
pF1KE4 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 QFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKA
370 380 390 400 410 420
430 440 450 460 470 480
pF1KE4 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 AYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYL
430 440 450 460 470 480
490
pF1KE4 YNWRCPGTDSEKVGLVLQ
::::::::::::
XP_016 YNWRCPGTDSEKALYQPLKKSI
490 500
>>NP_001295224 (OMIM: 603801) glycylpeptide N-tetradecan (485 aa)
initn: 2809 init1: 2809 opt: 2814 Z-score: 2615.4 bits: 493.4 E(85289): 6.1e-139
Smith-Waterman score: 2820; 90.6% identity (95.1% similar) in 467 aa overlap (46-498:21-485)
20 30 40 50 60
pF1KE4 LDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPNS--------------
:......::... :..
NP_001 MRRRRSTPKEVLEGIWEPKRKRRNRREKRRNQIPEAPSQTRHLIPRRLKF
10 20 30 40 50
70 80 90 100 110 120
pF1KE4 GGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQF
.. .. . : :. .. .:: :::::::::::::::::::::::::::::::::::::::
NP_001 SSLRNTTPSGSR-FQREQP-WNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQF
60 70 80 90 100
130 140 150 160 170 180
pF1KE4 WDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNEN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 WDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNEN
110 120 130 140 150 160
190 200 210 220 230 240
pF1KE4 YVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSV
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 YVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSV
170 180 190 200 210 220
250 260 270 280 290 300
pF1KE4 KKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHR
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 KKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHR
230 240 250 260 270 280
310 320 330 340 350 360
pF1KE4 SLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQ
::::.:::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 SLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQ
290 300 310 320 330 340
370 380 390 400 410 420
pF1KE4 FHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAA
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 FHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAA
350 360 370 380 390 400
430 440 450 460 470 480
pF1KE4 YSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_001 YSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLY
410 420 430 440 450 460
490
pF1KE4 NWRCPGTDSEKVGLVLQ
:::::::::::::::::
NP_001 NWRCPGTDSEKVGLVLQ
470 480
>>XP_016872438 (OMIM: 603801) PREDICTED: glycylpeptide N (482 aa)
initn: 2774 init1: 2774 opt: 2779 Z-score: 2583.0 bits: 487.4 E(85289): 3.9e-137
Smith-Waterman score: 2785; 90.2% identity (95.4% similar) in 460 aa overlap (46-492:21-479)
20 30 40 50 60
pF1KE4 LDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPNSGG------------
:......::... :.. .
XP_016 MRRRRSTPKEVLEGIWEPKRKRRNRREKRRNQIPEAPSQTRHLIPRRLKF
10 20 30 40 50
70 80 90 100 110 120
pF1KE4 -TKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW
. ... ...... .:: ::::::::::::::::::::::::::::::::::::::::
XP_016 SSLRNTTPSGSRFQREQP-WNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW
60 70 80 90 100
130 140 150 160 170 180
pF1KE4 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY
110 120 130 140 150 160
190 200 210 220 230 240
pF1KE4 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK
170 180 190 200 210 220
250 260 270 280 290 300
pF1KE4 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS
230 240 250 260 270 280
310 320 330 340 350 360
pF1KE4 LNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF
:::.::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF
290 300 310 320 330 340
370 380 390 400 410 420
pF1KE4 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY
350 360 370 380 390 400
430 440 450 460 470 480
pF1KE4 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
410 420 430 440 450 460
490
pF1KE4 WRCPGTDSEKVGLVLQ
::::::::::
XP_016 WRCPGTDSEKKVC
470 480
>>XP_016872437 (OMIM: 603801) PREDICTED: glycylpeptide N (489 aa)
initn: 2774 init1: 2774 opt: 2779 Z-score: 2582.9 bits: 487.4 E(85289): 3.9e-137
Smith-Waterman score: 2785; 90.2% identity (95.4% similar) in 460 aa overlap (46-492:21-479)
20 30 40 50 60
pF1KE4 LDDQDTCGIDGDNEEETEHAKGSPGGYLGAKKKKKKQKRKKEKPNSGG------------
:......::... :.. .
XP_016 MRRRRSTPKEVLEGIWEPKRKRRNRREKRRNQIPEAPSQTRHLIPRRLKF
10 20 30 40 50
70 80 90 100 110 120
pF1KE4 -TKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW
. ... ...... .:: ::::::::::::::::::::::::::::::::::::::::
XP_016 SSLRNTTPSGSRFQREQP-WNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKHRYQFW
60 70 80 90 100
130 140 150 160 170 180
pF1KE4 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 DTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLLNENY
110 120 130 140 150 160
190 200 210 220 230 240
pF1KE4 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 VEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIYDSVK
170 180 190 200 210 220
250 260 270 280 290 300
pF1KE4 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 KMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRYWHRS
230 240 250 260 270 280
310 320 330 340 350 360
pF1KE4 LNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF
:::.::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTYLKQF
290 300 310 320 330 340
370 380 390 400 410 420
pF1KE4 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 HLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSLKAAY
350 360 370 380 390 400
430 440 450 460 470 480
pF1KE4 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 SFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
410 420 430 440 450 460
490
pF1KE4 WRCPGTDSEKVGLVLQ
::::::::::
XP_016 WRCPGTDSEKALYQPLKKSI
470 480
>>XP_016872442 (OMIM: 603801) PREDICTED: glycylpeptide N (411 aa)
initn: 2772 init1: 2772 opt: 2772 Z-score: 2577.6 bits: 486.2 E(85289): 7.8e-137
Smith-Waterman score: 2772; 99.8% identity (100.0% similar) in 411 aa overlap (88-498:1-411)
60 70 80 90 100 110
pF1KE4 KPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKH
::::::::::::::::::::::::::::::
XP_016 MQKLQDIQRAMELLSACQGPARNIDEAAKH
10 20 30
120 130 140 150 160 170
pF1KE4 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL
40 50 60 70 80 90
180 190 200 210 220 230
pF1KE4 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI
100 110 120 130 140 150
240 250 260 270 280 290
pF1KE4 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR
160 170 180 190 200 210
300 310 320 330 340 350
pF1KE4 YWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT
::::::::.:::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 YWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT
220 230 240 250 260 270
360 370 380 390 400 410
pF1KE4 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS
280 290 300 310 320 330
420 430 440 450 460 470
pF1KE4 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ
340 350 360 370 380 390
480 490
pF1KE4 YYLYNWRCPGTDSEKVGLVLQ
:::::::::::::::::::::
XP_016 YYLYNWRCPGTDSEKVGLVLQ
400 410
>>XP_016872441 (OMIM: 603801) PREDICTED: glycylpeptide N (415 aa)
initn: 2737 init1: 2737 opt: 2737 Z-score: 2545.2 bits: 480.2 E(85289): 5e-135
Smith-Waterman score: 2737; 99.8% identity (100.0% similar) in 405 aa overlap (88-492:1-405)
60 70 80 90 100 110
pF1KE4 KPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARNIDEAAKH
::::::::::::::::::::::::::::::
XP_016 MQKLQDIQRAMELLSACQGPARNIDEAAKH
10 20 30
120 130 140 150 160 170
pF1KE4 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 RYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTL
40 50 60 70 80 90
180 190 200 210 220 230
pF1KE4 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRI
100 110 120 130 140 150
240 250 260 270 280 290
pF1KE4 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 YDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCR
160 170 180 190 200 210
300 310 320 330 340 350
pF1KE4 YWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT
::::::::.:::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 YWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINT
220 230 240 250 260 270
360 370 380 390 400 410
pF1KE4 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 YLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKS
280 290 300 310 320 330
420 430 440 450 460 470
pF1KE4 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_016 LKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQ
340 350 360 370 380 390
480 490
pF1KE4 YYLYNWRCPGTDSEKVGLVLQ
:::::::::::::::
XP_016 YYLYNWRCPGTDSEKALYQPLKKSI
400 410
>>NP_066565 (OMIM: 160993) glycylpeptide N-tetradecanoyl (496 aa)
initn: 2569 init1: 2383 opt: 2450 Z-score: 2278.2 bits: 431.0 E(85289): 3.7e-120
Smith-Waterman score: 2515; 73.0% identity (88.6% similar) in 508 aa overlap (1-498:1-496)
10 20 30 40 50
pF1KE4 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK
::..::.:.. . : . .. :. : .:::.. . .: ::.. :::::::
NP_066 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK
10 20 30 40 50
60 70 80 90 100 110
pF1KE4 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN
:::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::..
NP_066 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT
60 70 80 90 100
120 130 140 150 160 170
pF1KE4 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV
..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :
NP_066 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV
110 120 130 140 150 160
180 190 200 210 220 230
pF1KE4 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA
::::::::::::::::::::::::::::::::::::::: :::::::: :..::::::::
NP_066 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA
170 180 190 200 210 220
240 250 260 270 280 290
pF1KE4 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP
:::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::::::
NP_066 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP
230 240 250 260 270 280
300 310 320 330 340 350
pF1KE4 KPIATCRYWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS
::..:::::::::::.::.::::::::::::.::::::::::.. ::.:::::: :::
NP_066 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV
290 300 310 320 330 340
360 370 380 390 400 410
pF1KE4 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM
:..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:
NP_066 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM
350 360 370 380 390 400
420 430 440 450 460 470
pF1KE4 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG
.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::::::
NP_066 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFG
410 420 430 440 450 460
480 490
pF1KE4 IGDGNLQYYLYNWRCPGTDSEKVGLVLQ
:::::::::::::.::. .::::::::
NP_066 IGDGNLQYYLYNWKCPSMGAEKVGLVLQ
470 480 490
>>XP_011523160 (OMIM: 160993) PREDICTED: glycylpeptide N (515 aa)
initn: 2272 init1: 2058 opt: 2125 Z-score: 1977.1 bits: 375.4 E(85289): 2.2e-103
Smith-Waterman score: 2190; 71.2% identity (87.9% similar) in 455 aa overlap (1-445:1-443)
10 20 30 40 50
pF1KE4 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK
::..::.:.. . : . .. :. : .:::.. . .: ::.. :::::::
XP_011 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK
10 20 30 40 50
60 70 80 90 100 110
pF1KE4 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN
:::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::..
XP_011 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT
60 70 80 90 100
120 130 140 150 160 170
pF1KE4 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV
..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :
XP_011 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV
110 120 130 140 150 160
180 190 200 210 220 230
pF1KE4 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA
::::::::::::::::::::::::::::::::::::::: :::::::: :..::::::::
XP_011 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA
170 180 190 200 210 220
240 250 260 270 280 290
pF1KE4 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP
:::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::::::
XP_011 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP
230 240 250 260 270 280
300 310 320 330 340 350
pF1KE4 KPIATCRYWHRSLNPKKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS
::..:::::::::::.::.::::::::::::.::::::::::.. ::.:::::: :::
XP_011 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV
290 300 310 320 330 340
360 370 380 390 400 410
pF1KE4 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM
:..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:
XP_011 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM
350 360 370 380 390 400
420 430 440 450 460 470
pF1KE4 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG
.::.::::::::::::.::.:::::::::::.:::
XP_011 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMVRSRRGGLWRCAGKRQWSHGEHSS
410 420 430 440 450 460
480 490
pF1KE4 IGDGNLQYYLYNWRCPGTDSEKVGLVLQ
XP_011 RDAASHGLEALSPPHLFCLGRVPAVFRQKLKTWREQGASEVKALNSS
470 480 490 500 510
498 residues in 1 query sequences
60827320 residues in 85289 library sequences
Tcomplib [36.3.4 Apr, 2011] (8 proc)
start: Sat Nov 5 22:35:47 2016 done: Sat Nov 5 22:35:48 2016
Total Scan time: 6.400 Total Display time: 0.050
Function used was FASTA [36.3.4 Apr, 2011]